Lymphoma

Although rare, primary thyroid lymphoma should be considered in cases of rapidly growing goiters. Timely needle biopsy can avoid unnecessary surgery.

Increasing intense physical activity levels over a year reduced fatigue among adult childhood cancer survivors enrolled in the SURfit trial.

A case series of three patients suggests that obinutuzumab-induced acute thrombocytopenia is a frequent, possibly non-relapsing, and unique adverse event that deserves more attention than it currently receives.

Richter’s transformation is a rare complication of chronic lymphocytic leukemia that is associated with poor outcomes. The evolving landscape of its treatment is discussed in this review.

PCNSL is a B-cell non-Hodgkin lymphoma in the brain, spinal cord, CSF, or eyes, without systemic manifestations. Though relapses are common, PCNSL is treatable in most cases, making timely diagnosis and treatment essential.

A wide range of complementary and integrative approaches are being studied in lymphoma and may prove beneficial for patients. But better patient–practitioner communication and systematic evaluation of potential safety issues are crucial.

Although cauda equina syndrome in the context of secondary CNS lymphoma is a rare occurrence, it should be considered in at-risk patients, especially those presenting with abnormal neurological findings.

Two new classification systems for T/NK-cell lymphomas and lymphoproliferative disorders were released recently. This review provides a summary of the updates and highlights the similarities and differences between the systems.

A 68-year-old woman was admitted to the emergency department with headache, mental confusion, and a mild hemiparesis. Explore the imaging findings, differential diagnosis, and histopathological findings that revealed the patient’s diagnosis.

The key clinical trial results for agents targeting the PI3K/AKT/mTOR signaling pathway in cancer are outlined and the major mechanisms of resistance to these inhibitors are discussed.

Lymphoma patients at high risk for anthracycline-associated cardiac dysfunction may benefit from the prophylactic use of atorvastatin.

First-line treatment with single-agent brentuximab vedotin shows promise in two patients with Hodgkin lymphoma and severe hepatic impairment.

A case of myelodysplastic syndrome developing 21 months after CAR T-cell therapy as a potential long-term consequence of this new strategy.

Anthracycline exposure in young adults who previously received cancer treatment is associated with a significantly elevated risk for heart failure.

Systematic investigation of anemia in a patient receiving immune checkpoint inhibitor treatment for metastatic castration-resistant prostate cancer revealed a diagnosis of secondary pure red cell aplasia with underlying Waldenström macroglobulinemia.

The use of immune checkpoint inhibitors is not associated with excess toxicity in people living with HIV and a concomitant diagnosis of cancer.

Pure red cell aplasia is a rare side effect of bendamustine and should be considered if anemia progresses during treatment with regimens containing the drug.